Dr. Sarah Regan is a hematologist and medical oncologist who was born and raised in Maryland. She attended the University of Maryland School of Medicine and completed her residency at the University of Maryland Medical Center. She went on to a fellowship in hematology and medical oncology at the NCI-designated University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Her professional interests include gastrointestinal, breast, genitourinary, and thoracic oncology, as well as benign hematology.
She is committed to providing compassionate, high-quality care to her patients and emphasizes the importance of clear communication. Outside of work, she enjoys spending time with her husband and family, traveling, hiking, gardening, and going to baseball games.
Dr. Najeff Waseem joined Maryland Oncology Hematology in August 2022. Dr. Waseem received his medical degree from the George Washington School of Medicine and Health Sciences, where he was named a member of the Alpha Omega Alpha Honor Medical Society. He completed an internal medicine residency at Stanford, and a post-doctoral fellowship in hematology and oncology at Johns Hopkins Hospital. He is board certified in medical oncology by the American Board of Internal Medicine. He has published in both JAMA Oncology and Journal of Clinical Oncology. Dr. Waseem is a member of the American Society of Hematology and the American Society of Clinical Oncology.
Outside of medicine, Dr. Waseem enjoys creative writing, reading, sports, cooking, strategy games, and travel. He is a Ravens fan and season ticket holder!
He speaks English, Spanish, and Urdu.
Dr. Albert J. Steren, MD, FACOG, has over 30 years of experience in Obstetrics, Gynecology, and Gynecologic Oncology and will be joining Mayland Oncology Hematology at the Aquilino Cancer center in August. He comes from Women’s Health Specialists of Montgomery County, where he has practiced for the last 20 years. A leader in the field of minimally invasive gynecologic surgery and medical director of an AAGL-certified fellowship in minimally invasive surgery. Dr. Steren is also an associate clinical professor at Uniformed Services University of the Health Sciences and an assistant clinical professor at George Washington University School of Medicine. Dr. Steren has received numerous awards, including being named to Newsweek’s list of top oncologists and multiple Top Doctors distinctions from Washingtonian magazine, Bethesda magazine, and U.S. News & World Report. Dr. Steren performed the first robotic surgery in Montgomery County in 2008.
Shruti Murali, MD, is originally from New Jersey. She did her medical school training in India, internal medicine residency at the University of Connecticut, and Fellowship training in Hematology and Oncology at the University of Maryland Medical Center.. Since then, Dr. Murali has stayed locally in Baltimore County to work at the University of Maryland St. Joseph Medical Center. I have an interest in Breast Oncology, Thoracic, GI/GU Oncology, and Hematology.
In practice, she values communication with patients and their family members to help them make the best treatment decision tailored to their personal medical history. She enjoys traveling, spending time with her husband, family, friends, and growing baby girl.
Dr. Barter is recognized as one of the country’s leading gynecologists by Good Housekeeping, perennially as one of the Top Doctors in the Washington, D.C. area, as well as one of only two Gynecologic Oncologists noted as top doctors in Northern Virginia. He is currently a Clinical Professor at George Washington University and director of Gynecologic Oncology research at Holy Cross Hospital. He received his medical degree from the University of Virginia and completed two years of Internal Medicine and four years of Obstetrics and Gynecology at Duke University Medical Center, followed by a fellowship in Gynecologic Oncology at the University of Alabama Medical Center. He was then at Lombardi Cancer Center / Georgetown University Medical Center for 16 years, rising to the rank of Professor. Dr. Barter joined Maryland Oncology Hematology in April 2022 at White Oak Cancer Center. Dr. Barters’ current interests include surgery using the Da Vincia surgical robot to assist in Gynecologic surgery.
He has lectured locally and internationally on this topic. He was recently ranked in the top 15 users worldwide for robotic gynecologic and gynecologic oncology procedures and is presenting the Holy Cross Gynecologic and Gynecologic Oncology experience at the Middle Atlantic Gynecologic Oncology Symposium. His four-year interest in the development of a serum blood test for Ovarian Cancer detection will soon culminate in published research involving Serum Proteomics. In conjunction with Holy Cross, he continues his interest in protocols dealing with novel approaches for Ovarian Cancer treatment, having received research grants. A novel study to determine cancer cell sensitivity to chemotherapy has just begun.
Dr. Adam Goldrich attended Binghamton University, renowned as one of the top public research universities in the U.S., where he received a Bachelor of Science degree in Chemistry and then attended Tel Aviv University – Sackler School of Medicine, a global leader in cancer and molecular biomedical research. As a medical student, he worked at a specialized clinic that provides medical care for undocumented immigrants administered by the internationally renowned Physicians for Human Rights. Upon graduating from medical school, he completed his internal medicine residency at SUNY Downstate Health Sciences University. Following his residency, he was elected by his peers to be the Chief Resident at the world-renowned Kings County Hospital in Brooklyn, NY. Dr. Goldrich trained as a fellow in medical oncology and hematology at Temple University Hospital’s Fox Chase Cancer Center.
While at Fox Chase Cancer Center, Dr. Goldrich was actively involved in clinical trials, focusing on immunotherapeutic treatments in cancer care and thoracic oncology research trials as a member of the Chest Steering Committee. In 2018, he moved to Annapolis, to practice medical oncology and hematology in the community. He joined Maryland Oncology Hematology in October 2020.
Dr. Goldrich has leveraged his oncology and hematology expertise for continuing research in the use of immunotherapy and has given specific attention to comprehensive genomic tumor profiling and targeted therapies for the treatment of cancer. His clinical focus is on gastrointestinal cancers such as esophageal, stomach, pancreatic, liver, and colorectal cancers. He also has a focus on lung cancer, head and neck cancer, leukemia, and lymphoma.
Dr. Goldrich believes strongly in the autonomy of his patients. He understands the need for, and truly enjoys, developing close relationships with his patients and their families. He prides himself on being available to his patients for both clinical and non-clinical issues. He resides in Maryland with his wife and 2 young children. He enjoys spending time with his family and reading to his son and daughter. In addition, he enjoys traveling, trail running, and basketball. Dr. Goldrich won his NCAA tournament bracket in 2021.
Dr. Carol Tweed attended Duke University, where she was inducted into Phi Beta Kappa. She graduated summa cum laude with a degree in Biology, and a concentration in molecular biology. She received her medical degree from Washington University in St. Louis, where she was elected to Alpha Omega Alpha. She then completed her Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Pennsylvania.
From 2006-2012, Dr. Tweed was an Assistant Professor on faculty at the University of Pennsylvania’s Abramson Cancer Center. During this time, she practiced as a breast oncology specialist and enthusiastically educated medical students, residents, and fellows.
In 2012, she moved to Annapolis, MD, practicing medical oncology and hematology, and joined Maryland Oncology Hematology in October 2020. Dr. Tweed passionately cares for patients with a broad range of hematologic and oncologic disorders. Her work as a breast medical oncology expert continues. She serves as a member of the Editorial Board of the (National Cancer Institute) NCI PDQ. She is a regional speaker on the topics of breast cancer and cancer genomics. She received her certification in genetic cancer risk assessment through the City of Hope via completion of the Intensive Course in Genomic Cancer Risk Assessment in 2022. Also, Dr. Tweed is a co-founder and co-director of the Maryland Breast Cancer Consortium.
Dr. Tweed is an active clinical researcher; she has served as principal investigator on numerous clinical trials. She also is an Instructor of Medicine/preceptor for Johns Hopkins School of Medicine, educating medical students.
Benjamin Bridges, MD, joined Maryland Oncology Hematology in October 2020. Dr. Bridges completed his medical school at the University of Tennessee in 2001. Dr. Bridges went on to complete his internship at the University of Maryland and his fellowship at the University of Maryland’s Marlene & Stewart Greenbaum Comprehensive Cancer Center.
Before joining Maryland Oncology Hematology, Dr. Bridges practiced at St. Luke’s Cancer Institute in Boise, Idaho, for 11 years where he served as Chairman of the Department of Oncology, Research Director for the Cancer Institute, and Medical Director for St. Luke’s Cancer Institute in Meridian, Idaho. In his role as Research Director for the Cancer Institute, he served as a principal investigator for the Pacific Cancer Research Consortium, one of the largest National Cancer Institute Community Oncology Research Programs in the country.
Dr. Weng provides compassionate, state-of-the-art patient care. He is devoted to understanding, effectively communicating, and meeting the needs of each patient and their family. He has practiced at the following leading academic medical centers: Cleveland Clinic, National Cancer Institute, Johns Hopkins Hospital, and community medical centers throughout Maryland and Ohio. In addition, Dr. Weng has trained the next generation of oncologists, directing the hematology/oncology fellowship training program at the Cleveland Clinic.
He continues his work in clinical research through Maryland Oncology Hematology and assists patients to find and evaluate the best care available. His extensive research expertise in the laboratory and clinical trials with the pharmaceutical industry and leading academic institutions are highlighted in his publications, patents, and speaking engagements.